This compound is primarily used in the synthesis of nucleoside analogs, which are crucial in the development of antiviral and anticancer drugs. Its structure, featuring protected hydroxyl groups, allows for precise manipulation in organic synthesis, particularly in the construction of complex nucleotide frameworks. The tert-butyldimethylsilyl (TBDMS) groups serve as protective moieties, ensuring selective reactivity during multi-step synthetic processes. This chemical is often employed in the preparation of modified nucleosides that target viral polymerases or cellular enzymes, making it valuable in medicinal chemistry research. Additionally, it plays a role in the study of nucleic acid interactions and the development of therapeutic agents for diseases like HIV, hepatitis, and certain cancers.